Nanoparticles facilitated drug accumulation in tumor cells and down-regulated of survivin shRNA into nuclei of lung cancer cells lowering the apoptosis threshold of drug resistant cells and renders chemotherapeutic agents more effective to overcome MDR (Shen et al., 2012). Here, BIRC5 is linked to lung cancer.